A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...
Multiple myeloma diagnosis integrates blood tests, genetic assessments, and imaging to guide personalized treatment and patient engagement. Smoldering multiple myeloma involves active surveillance to ...
It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.
MedPage Today on MSN
Myeloma Drug Performs Well in Autoimmune Diseases
Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.
Bouchard opened a discussion on sequencing therapies in MM, noting that CAR T-cell therapy and bispecific antibodies each ...
Belantamab mafodotin (Blenrep), pomalidomide (Pomalyst), and dexamethasone (BPd) was well tolerated and led to deep responses ...
MedPage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results